Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non‐small cell lung cancer

Abstract Background The efficacy of rechallenge with immune checkpoint inhibitors (ICIs) in non‐small cell lung cancer (NSCLC) patients has not yet been fully clarified. This study aimed to identify the clinical characteristics of patients with NSCLC who benefited from rechallenge with ICIs. Methods...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2022-02-01
coleção:	Thoracic Cancer
Assuntos:	immune checkpoint inhibitors lung neoplasm non‐small‐cell lung carcinoma
Acesso em linha:	https://doi.org/10.1111/1759-7714.14309
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!